Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine Subcutaneous Bolus for Refractory Wound Pain in Palliative Care
NCT02587130Phase 4Terminated
- Sponsor
- Université Catholique de Lille
- Start
- May 2016
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ketamine in pain, sponsored by Université Catholique de Lille. Started May 2016; status: terminated.
02
Drugs
ketamine
03
Conditions
pain
Beyond the preview
Go deeper on NCT02587130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02587130.